U.S. Dollar Falls Against Euro, Pound

The U.S. dollar weakened against the euro and the pound in the Asian session on Wednesday. The U.S. dollar fell to nearly a 1-week low of 1.0715 against the euro, from yesterday\'s closing value of 1.0699. Against the pound, the greenback slid to a 5-day low of 1.2465 from Tuesday\'s closing value of 1.2448. If...

Read More

Yen Declines To Multi-decade Low

The Japanese yen weakened against their major currencies in the Asian session on Wednesday, as markets expect currency intervention by Japanese authorities to prop up the currency ahead of this week\'s Bank of Japan policy meeting. Traders await the BOJ\'s two-day policy meeting starts on Thursday for cues on when the central bank will raise...

Read More

Asian Markets Climb Led By Tech Stocks

Asian stocks advanced on Wednesday as focus remained on earnings reports from the U.S. megacaps due this week. Facebook owner Meta Platforms will declare its first-quarter earnings later today, while Microsoft and Alphabet will report their financial results on Thursday. Electric vehicle giant Tesla announced plans to introduce new vehicle models earlier than previously anticipated,...

Read More

Bitcoin Price Prediction as Bulls Push BTC Higher Toward $70,000 – What is the Next Target?

As Bitcoin (BTC/USD) hovers around $66,980, up approximately 1%, attention intensifies on its upward trajectory, potentially surging towards $70,000. Recent developments in the cryptocurrency market, particularly the influx of $59.7 million into U.S. Bitcoin ETFs after a period of outflows, signal a shift in sentiment. As institutional players like Grayscale’s GBTC near 300,000 Bitcoins, and...

Read More

Ascendis Pharma Says UK Approves YORVIPATH For Treatment Of Adults With Chronic Hypoparathyroidism

Danish pharmaceutical company Ascendis Pharma A/S (ASND) announced that the United Kingdom\'s Medicines & Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for YORVIPATH (palopegteriparatide; developed as TransCon PTH) in Great Britain as a parathyroid hormone (PTH) replacement therapy indicated for the treatment of adults with chronic hypoparathyroidism The MHRA has also granted YORVIPATH...

Read More

Coca-Cola Invests $1.1 Billion in Collaborative Generative AI Project with Microsoft

Coca-Cola inked a $1.1 billion five-year partnership deal on April 23 with Microsoft to explore and integrate the tech company’s cloud and artificial intelligence (AI) solutions across the beverage giant’s global operations. According to the Coca-Cola AI agreement with Microsoft, the beverage production company will collaborate on experimenting with its Azure cloud computing platform. Coca-Cola...

Read More